Daniel Arias

Stock Analyst at Stifel

(5.00)
# 11
Out of 5,147 analysts
169
Total ratings
58.16%
Success rate
137.55%
Average return

Stocks Rated by Daniel Arias

Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $120$130
Current: $93.90
Upside: +38.45%
10x Genomics
Feb 13, 2026
Maintains: Buy
Price Target: $15$20
Current: $23.05
Upside: -13.23%
Qiagen
Feb 6, 2026
Maintains: Hold
Price Target: $45$50
Current: $49.80
Upside: +0.40%
Bio-Techne
Feb 5, 2026
Maintains: Hold
Price Target: $60$65
Current: $59.00
Upside: +10.17%
Illumina
Jan 20, 2026
Maintains: Buy
Price Target: $135$155
Current: $134.46
Upside: +15.28%
Thermo Fisher Scientific
Jan 9, 2026
Maintains: Buy
Price Target: $583$700
Current: $521.11
Upside: +34.33%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $76.33
Upside: +89.96%
Exact Sciences
Nov 28, 2025
Downgrades: Hold
Price Target: $80$105
Current: $103.38
Upside: +1.57%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450$1,600
Current: $1,366.69
Upside: +17.07%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48$40
Current: $40.11
Upside: -0.27%
Maintains: Hold
Price Target: $14$12
Current: $9.05
Upside: +32.60%
Maintains: Hold
Price Target: $120$110
Current: $98.31
Upside: +11.89%
Upgrades: Buy
Price Target: $260
Current: $210.64
Upside: +23.43%
Maintains: Buy
Price Target: $11$9
Current: $0.81
Upside: +1,009.33%
Maintains: Buy
Price Target: $17$6
Current: $6.90
Upside: -13.04%
Downgrades: Hold
Price Target: $45$65
Current: $53.25
Upside: +22.07%
Maintains: Hold
Price Target: $332$360
Current: $319.38
Upside: +12.72%
Maintains: Buy
Price Target: $163$151
Current: $121.38
Upside: +24.40%
Maintains: Buy
Price Target: $11$10
Current: $3.56
Upside: +180.90%
Maintains: Buy
Price Target: $165$207
Current: $128.73
Upside: +60.80%
Maintains: Buy
Price Target: $9$5
Current: $1.01
Upside: +395.05%
Maintains: Hold
Price Target: $28$10
Current: $2.74
Upside: +264.96%